title: Clinical features of bacteremia due to Campylobacter jejuni.
abstract: OBJECTIVE
  The clinical features of bacteremia due to Campylobacter jejuni (C. jejuni) have yet to be fully elucidated.
  
  
  RESULTS
  The cases of C. jejuni bacteremia were retrospectively reviewed during a twelve-year period in a single institute. C. jejuni was identified in 7 patients through blood cultures, and disease onset occurred between June and October. Except for 2 previously healthy individuals, 5 patients had underlying diseases (chronic liver diseases, n=3; hematological malignancies, n=2). All patients were febrile, but 2 patients did not present with gastrointestinal symptoms. C. jejuni isolates were susceptible to gentamicin and macrolides, but about half of them were resistant to fluoroquinolones. Disease outcomes were favorable, and no deaths related to C. jejuni bacteremia were observed.
  
  
  CONCLUSIONS
  These results suggest that C. jejuni bacteremia could occur primarily or secondarily to gastroenteritis with a seasonal peak and that prognosis would be favorable regardless of the underlying diseases.
authors.affiliation: Center for Infectious Diseases and Infection Control, Keio University School of Medicine, Japan.
authors.forename: Takehiko
authors.initials: T
authors.lastname: Mori
authors.forename: Naoki
authors.initials: N
authors.lastname: Hasegawa
authors.forename: Kayoko
authors.initials: K
authors.lastname: Sugita
authors.forename: Masayoshi
authors.initials: M
authors.lastname: Shinjoh
authors.forename: Nobuhiro
authors.initials: N
authors.lastname: Nakamoto
authors.forename: Takayuki
authors.initials: T
authors.lastname: Shimizu
authors.forename: Shingo
authors.initials: S
authors.lastname: Hori
authors.forename: Osamu
authors.initials: O
authors.lastname: Iketani
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Fujiwara
authors.forename: Yaoko
authors.initials: Y
authors.lastname: Takano
authors.forename: Satoshi
authors.initials: S
authors.lastname: Iwata
mesh_terms: D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D002169:Campylobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016123:Campylobacter jejuni / Q000302:isolation & purification*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000890:Anti-Infective Agents